Exosomes Treatment Mitigates Ischemic Brain Damage but Does Not Improve Post-Stroke Neurological Outcome

BACKGROUND/AIMS: Recent studies demonstrated that the treatment with mesenchymal stem cells (MSCs) obtained from the human umbilical cord blood improved survival, reduced brain damage, prevented apoptosis, suppressed inflammatory responses, downregulated the DNA damage-inducing genes, upregulated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Nalamolu, Koteswara Rao, Venkatesh, Ishwarya, Mohandass, Adithya, Klopfenstein, Jeffrey D., Pinson, David M., Wang, David Z., Veeravalli, Krishna Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996798/
https://www.ncbi.nlm.nih.gov/pubmed/31026391
http://dx.doi.org/10.33594/000000090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996798/
https://www.ncbi.nlm.nih.gov/pubmed/31026391
http://dx.doi.org/10.33594/000000090

Ejemplares similares